Pharmaceutical and therapeutic applications of artificial cells including microencapsulation

This publication has 28 references indexed in Scilit:

• Recent and Future Developments in Modified Hemoglobin and Microencapsulated Hemoglobin as Red Blood Cell Substitutes
  Artificial Cells, Blood Substitutes, and Biotechnology, 1997
• Preparation and in vitro analysis of microencapsulated genetically engineered E. coli DH5 cells for urea and ammonia removal
  Biotechnology and Bioengineering, 1995
• Kinetic Analysis of UDP‐Glucuronosyltransferase in Bilirubin Conjugation by Encapsulated Hepatocytes for Transplantation into Gunn Rats
  Artificial Organs, 1995
• News on Artificial Cells, Blood Substitutes & Immobilization Biotechnology
  Artificial Cells, Blood Substitutes, and Biotechnology, 1994
• MICROENCAPSULATED XANTHINE OXIDASE AS EXPERIMENTAL THERAPY IN LESCH-NYHAN DISEASE
  The Lancet, 1989
• Hepatocytes Immobilised by Microencapsulation in Artificial Cells: Effects on Hyperbilirubihemia in Gunn Rats
  Biomaterials, Artificial Cells and Artificial Organs, 1989
• Preparation and Characterisation of Xanthine Oxidase Immobilised by Microencapsulation in Artificial Cells for the Removal of Hypoxanthine
  Biomaterials, Artificial Cells and Artificial Organs, 1989
• Plasma/intestinal Concentration Patterns Suggestive of Entero-Portal Recirculation of Amino Acids: Effects of Oral Administration of Asparaginase, Glutaminase and Tyrosinase Immobilized by Microencapsulation in Artificial Cells
  Biomaterials, Artificial Cells and Artificial Organs, 1988
• 30th Anniversary in Artificial Red Blood Cell Research
  Biomaterials, Artificial Cells and Artificial Organs, 1988
• The in vivo Effects of Semipermeable Microcapsules containing L-Asparaginase on 6C3HED Lymphosarcoma
  Nature, 1971